Paul Lytle

Patriot Scientific Corp. is a intellectual property licensing company, which engages in the design and development of microprocessor chips. Its technologies are used in computers, printers, automobiles, and industrial devices. The company was founded on June 10, 1987 and is headquartered in Carlsbad, CA.

Breathe Technologies, Inc. develops and manufactures chronic obstructive pulmonary disease therapy devices. The firm offers NIOV product. It provides ultra-lightweight, compact and wearable ventilators designed to improve breathing and to facilitate the mobility required for normal activities of daily life. The company was founded in January 2005 by Lutz Freitag, Spencer J. Volk and Gregory J. Kapust and is headquartered in Irvine, CA.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

Avid Bioservices, Inc. provides specialized cell cultures for biotechnology testing. Its services include cell line optimization, cell culture and purification process development, protein characterization, process optimization, scale-up and validation, cGMP clinical and commercial manufacturing, bulk filling, aseptic filling, analytical assay development, method qualification and validation, QC release and stability testing and regulatory strategy and submission. The company was founded by Steven W. King in 2001 and is headquartered in Tustin, CA.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Mosaic ImmunoEngineering Development Co. engages in the development of novel immunotherapies to treat and prevent cancer and infectious diseases. The company was founded by Steven King, Paul Lytle, Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, and Robert Garnick and is headquartered in the United States.